Effect of Bronchial Artery Protection on Cough After Thoracoscopic Lobectomy
Launched by THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY · Nov 25, 2020
Trial Information
Current as of May 27, 2025
Completed
Keywords
ClinConnect Summary
After pneumonectomy cough on patients' daily life will bring different degrees of adverse effects, so through certain methods to intervene, in order to reduce the incidence of postoperative cough, accelerate the rapid recovery of patients after surgery, improve the quality of life of patients, which should also be worthy of attention of surgeons. In recent years, the research on intervention measures and treatment methods to reduce cough after thoracoscopic lobectomy is mainly focused on drug treatment, traditional Chinese medicine treatment, surgical operation and anesthesia intervention. ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years, no matter male or female;No cough symptoms within two weeks before operation; Lung adenocarcinoma confirmed by pathology;Operation method: thoracoscopic lobectomy + systematic lymph node dissection;Preoperative abdominal B-ultrasound, skull CT / MRI, bone scan or PET / CT to exclude distant metastasis; ECG, lung function, cardiac ultrasound evaluation can tolerate the operation
- Exclusion Criteria:
- • There were cough caused by respiratory diseases, pharyngitis and rhinitis before operation; Pneumonia was indicated by chest X-ray or chest CT in recent month;Thoracoscopic surgery was converted to thoracotomy;Pulmonary arteriovenous angiography could not be performed in patients with allergy to contrast medium; Patients and their families refused to be enrolled and followed up.
About The First Affiliated Hospital Of Soochow University
The First Affiliated Hospital of Soochow University is a leading medical institution dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in various medical disciplines to facilitate high-quality, ethically conducted studies that aim to enhance treatment options and improve patient outcomes. With a commitment to collaboration and scientific rigor, the institution plays a pivotal role in contributing to the global body of medical knowledge while ensuring the highest standards of patient care and safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Suzhou, Jiangsu, China
Patients applied
Trial Officials
Jun Zhao
Study Director
The First Affiliated Hospital of Soochow University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials